Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...
A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.
It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...
A clinical trial reveals that benralizumab, an injectable drug for severe asthma, outperforms steroids in reducing asthma and ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...
A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...
Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.
The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...
The study assumes significance considering the rising complaints of COPD and asthma from polluted cities across India or as a ...
A 57-year-old woman with chronic obstructive pulmonary disease (COPD) has received the world's first fully robotic double ...
An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.